The same biological processes that drive aging — such as energy loss — may also contribute to lung diseases like chronic ...

Global Market Trends and Projections. The global market for Chronic Obstructive Pulmonary Disease (COPD) and asthma diagnostic and monitoring devices was valued at US$ 7.77 billio ...

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

Fisher & Paykel is well-positioned to benefit from long-term growth prospects in hospital and home respiratory care. Increasing adoption of nasal high flow, or NHF, therapy in the hospital division is ...

Emphysema, a progressive form of chronic obstructivepulmonary disease (COPD), is characterized by the destruction of alveoli, leading to hyperinflation of the lungs and impaired gas ...

Decreased levels of resolvin D1 are linked to prolonged respiratory symptoms and slower clinical recovery in patients with ...

Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...

The global chronic obstructive pulmonary disease market size is calculated at USD 23.55 billion in 2025 and is expected to ...

Struggling to manage hip pain due to arthritis, columnist Caroline Gainer recognizes she also needs help coping with ...

Dupilumab improved exacerbations and lung function in patients with COPD and T2 inflammation, regardless of baseline BODE index score.

Pulmonary sarcoidosis is a lung disease characterized by granulomas-tiny clumps of immune cells that form in response to ...

Verona is extending Ohtuvayre's life cycle through new formulations and fixed-dose combinations, aiming for cash flow ...